Transplant Pioneer Thomas E. Starzl Most Cited Researcher In Clinical Medicine Over Pas...( Five Others From University Of Pitt...)

Transplant Pioneer Thomas E. Starzl Most Cited Researcher In Clinical Medicine Over Past 17 Years

Five Others From University Of Pittsburgh Listed By The Institute For Scientific Information

PITTSBURGH, May 12 -- Transplant pioneer Thomas E. Starzl, M.D., Ph.D., has had the most impact in clinical medicine in the past 17 years, according to a ranking of the number of times researchers' publications have been cited by others in the medical literature. Dr. Starzl, professor of surgery at the University of Pittsburgh, tops the list compiled by the Institute for Scientific Information (ISI) and published in the May/June issue of ScienceWatch.

According to ISI, the ranking is a measure of a researcher's influence and his work's utility in the field of clinical medicine. Between Jan. 1981 and June 1998, Dr. Starzl's publications were cited 26,456 times, about 4,000 more times than the second-ranked researcher, Steven A. Rosenberg, M.D., of the National Cancer Institute. The ISI analysis included only those citations in clinical medicine journals.

ISI also examined citations in four main subfields: cardiology, oncology, surgery/transplantation and epidemiology. Dr. Starzl ranked first in the surgery/transplantation listing, and three other University of Pittsburgh researchers made this top-10 list as well. They are Shunzaburo Iwatsuki, M.D., professor of surgery at the Thomas E. Starzl Transplantation Institute, ranked 3rd; Satoru Todo, M.D., now of Hokkaido University School of Medicine in Japan, ranked 4th; and Richard L. Simmons, M.D., professor of surgery and former chairman of the department of surgery, ranked 6th. The top-10 list also includes two others who have trained and worked under Dr. Starzl at the University of Pittsburgh.

Michael T. Lotze, M.D., professor of surgery and molecular genetics and biochemistry at the University of Pittsburgh and co-director of the University of Pittsburgh Cancer Institute's Biological Therapeutics Program, was listed 10th in the oncology category.

Dr. Starzl performed the world's f
'"/>

Contact: Lisa Rossi
rossiL@msx.upmc.edu
412-624-2607
University of Pittsburgh Medical Center
12-May-1999

Page: 1 2
Related medicine news :

1. Transplanted bone marrow cells reduce liver fibrosis in mice
2. Transplant of pig tissue may reduce stroke size and damage
3. Roche pledges continued support for Organ Transplantation Research Foundation
4. Transplanted kidneys from living donors survive longer with Neoral compared with tacrolimus
5. National Conference on Organ Donation and Transplantation
6. Transplantation Society reiterates position against selling organs
7. Transplants in HIV patients should proceed, but drug interactions a concern
8. International Congress of the Transplantation Society beginning Sunday
9. JDRF launches multimillion-dollar Center for Islet Transplantation at Emory University
10. Transplanted human neural stem cells improve memory in rats
11. Kidney Transplants From Living Donors Reduce Long-Term Costs Of Care

Post Your Comments: